The University of North Carolina at Chapel Hill
Skip to main content
UNC School of Medicine

Category: Infectious Diseases

  • Myron Cohen, MD, and Joe Eron, MD

    NIH Awards Seven-Year Funding to HIV Prevention Trials Network, AIDS Clinical Trials Group Also Re-funded For Seven-Year Study

    Myron Cohen, MD, and Joe Eron, MD Myron S. Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and Wafaa El-Sadr, MD, MPH, MPA, director of ICAP at Columbia University, have received a seven-year award from the National Institutes of Health for leadership of the HIV Prevention Trials Network (HPTN) in collaboration with FHI 360. The first year of sup … Read more

  • eron-hosseinipour-wohl

    NIH Awards $25 Million to UNC’s Global HIV Clinical Trials Unit

    Joe Eron, MD, Mina Hosseinipour, MD, and David Wohl, MD The National Institutes of Health has awarded University of North Carolina’s Institute for Global Health & Infectious Diseases nearly $25 million over seven years to continue operating its Global HIV Clinical Trials Unit, or CTU. The new funding will support HIV treatment and prevention in adults, children and pregnant w … Read more

  • Myron Cohen, MD-ID-faculty-in-covid-news-dec-24-30

    Cohen Says This Will Be a Difficult Winter

    Myron Cohen, MD WTVD-11 News reports how the UK’s approval of the Pfizer vaccine could benefit North Carolina and asks who will get the vaccine first. Myron Cohen, MD, the Yeargan-Bate Distinguished Professor of Medicine in the division of infectious diseases, tells WTVD-11 that the coming winter will be difficult. “I think everybody is forewarning that the spike increase in case … Read more

  • CindyGay-newsworthy-nov-2021

    COVID Vaccine Trial Update

    Cindy Gay, MD, MPH Charlotte’s WBTV News interviewed Cindy Gay, MD, MPH, associate professor of medicine in the division of infectious diseases, for an update on the COVID vaccine trials. Gay shared her enthusiasm and confidence in the latest data. Watch the interview here.

  • Doctors Provide Up-Close View of Pandemic in Area Hospitals, Guidance On Limiting Viral Spread

    David Wohl, MD, talked about the pandemic with other infectious disease experts on WRAL. Infectious disease experts David Wohl, MD, Cameron Wolfe, MBBS (Duke University Health), and Chris DeRienzo, MD, MPP (WakeMed), discuss what they’re seeing at area hospitals during the pandemic and ways to slow the surge in new coronavirus infections. See this 30-minute round-table Zoom discu … Read more

  • david-wohl-tarheel-of-the-month

    Wohl Named Tar Heel of the Month

    David Wohl, MD (credit: Mark Derewicz) For his years of work studying infectious diseases and his role in helping North Carolina health professionals and residents respond to the pandemic, David Wohl, MD, is the News & Observer’s November Tar Heel of the Month, which honors people who have made significant contributions to North Carolina and the region.  Read the story in the … Read more

  • Wohl Honored With First Charles Van Der Horst Humanitarian Award

    David Wohl, left, takes a break while cycling with his former colleague and mentor, Charlie van der Horst (credit: UNC IGHID) The national AIDS Clinical Trials Group expanded its annual recognition program in 2020 with two new awards named for University of North Carolina faculty members who died in 2019: Charles van der Horst, MD, an infectious diseases physician and researcher, … Read more

  • Joe Eron, MD

    More COVID-19 Vaccine Options Could Aid Distribution Timeline, Especially in Rural Areas

    Joe Eron, MD News of Oxford University and AstraZeneca’s successful COVID-19 vaccine trial is inspiring increased optimism within the medical community. “We need billions of doses. And different vaccines have different upsides and downsides. Like the newest one we heard about yesterday, AstraZeneca. It’s easier to manufacture. So there (are) more doses that can be made, and proba … Read more

  • joe-eron

    Third Major Coronavirus Vaccine Shown To Be Effective and Cheaper

    Joseph Eron, MD An Associated Press article reports the “drugmaker AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.” Joe Eron, MD, chief of the division of infectious diseases, said that it is unclear … Read more

  • David Weber, MD, MPH

    COVID-19 Vaccines Are Coming. How Will NC Roll Out Doses, and Will People Accept Them?

    David Weber, MD, MPH From Governor Roy Cooper to infectious disease experts to ordinary residents, North Carolinians are thrilled by the prospects of two COVID-19 vaccines currently under trial with the U.S. Food and Drug Administration. “None of us can predict how many people will actually want the vaccine given people’s concerns for a variety of reasons,” said David Weber, MD, … Read more

  • CindyGay-newsworthy-nov-2021

    Moderna’s Initial Vaccine Results ‘More Than Hoped For,’ Says Gay

    Cindy Gay, MD, MPH Cindy Gay, MD, MPH, associate professor of medicine in the division of infectious diseases, oversees the clinical trial of Moderna’s coronavirus vaccine candidate at UNC-Chapel Hill. She says the high initial efficacy rate shown by the drug “was more than we were hoping for.” Listen to her interview with WRAL News.

  • Sidney Smith, MD, and Myron Cohen, MD

    Smith, Cohen Recognized in Clarivate’s 2020 list of Highly Cited Researchers

    Sidney Smith, MD, and Myron Cohen, MD Sidney Smith, MD, and Myron Cohen, MD, have been recognized in Clarivate’s 2020 list of Highly Cited Researchers™.  Altogether the list includes 20 UNC School of Medicine and 16 UNC Chapel Hill researchers who have demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during … Read more